Review
doi: 10.1016/s0896-6273(03)00195-8.
Finding the intracellular signaling pathways affected by mood disorder treatments
Affiliations
- PMID: 12718851
- DOI: 10.1016/s0896-6273(03)00195-8
Item in Clipboard
Review
Finding the intracellular signaling pathways affected by mood disorder treatments
Neuron.
.
Free article
Abstract
Postmortem and brain imaging studies have revealed structural changes and cell loss in cortico-limbic regions of the brain in bipolar disorder and major depression. Consistent with these findings, mood stabilizers such as lithium ion and valproic acid, which are used to treat bipolar disorder, as well as antidepressants and electroconvulsive therapy have recently been shown to activate interconnected intracellular signaling pathways that promote neurogenesis and synaptic plasticity. These insights should assist in understanding the pathophysiology of severe mood disorders as well as aid in the development of more effective treatments.
Similar articles
-
Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressants.Psychosom Med. 1999 Sep-Oct;61(5):599-617. doi: 10.1097/00006842-199909000-00004. Psychosom Med. 1999. PMID: 10511011 Review.
-
Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic system.Ann N Y Acad Sci. 2003 Nov;1003:273-91. doi: 10.1196/annals.1300.017. Ann N Y Acad Sci. 2003. PMID: 14684452 Review.
-
A role for the PKC signaling system in the pathophysiology and treatment of mood disorders: involvement of a functional imbalance?Mol Neurobiol. 2011 Dec;44(3):407-19. doi: 10.1007/s12035-011-8210-4. Epub 2011 Oct 5. Mol Neurobiol. 2011. PMID: 21983961 Review.
-
Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics.Psychopharmacol Bull. 2001 Spring;35(2):5-49. Psychopharmacol Bull. 2001. PMID: 12397885 Review.
-
[Mood stabilizers--past, present and future].Neuropsychopharmacol Hung. 2008 Mar;10(1):31-42. Neuropsychopharmacol Hung. 2008. PMID: 18771018 Review. Hungarian.
Cited by
-
Drug Repurposing Is a New Opportunity for Developing Drugs against Neuropsychiatric Disorders.Schizophr Res Treatment. 2016;2016:6378137. doi: 10.1155/2016/6378137. Epub 2016 Mar 17. Schizophr Res Treatment. 2016. PMID: 27073698 Free PMC article. Review.
-
Clinical value and mechanistic analysis of HIIT on modulating risk and symptoms of depression: A systematic review.Int J Clin Health Psychol. 2024 Jan-Mar;24(1):100433. doi: 10.1016/j.ijchp.2023.100433. Epub 2024 Jan 9. Int J Clin Health Psychol. 2024. PMID: 38226005 Free PMC article.
-
Gene expression analysis of novel genes in the prefrontal cortex of major depressive disorder subjects.Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:126-33. doi: 10.1016/j.pnpbp.2012.12.010. Epub 2012 Dec 20. Prog Neuropsychopharmacol Biol Psychiatry. 2013. PMID: 23261523 Free PMC article.
-
Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells.Proc Natl Acad Sci U S A. 2004 Nov 23;101(47):16659-64. doi: 10.1073/pnas.0407643101. Epub 2004 Nov 10. Proc Natl Acad Sci U S A. 2004. PMID: 15537713 Free PMC article.
-
Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia.J Affect Disord. 2010 Jul;124(1-2):164-9. doi: 10.1016/j.jad.2009.10.017. Epub 2009 Nov 13. J Affect Disord. 2010. PMID: 19913919 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
